These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 8510231)

  • 21. Differential regulation of the human immunodeficiency virus type 2 enhancer in monocytes at various stages of differentiation.
    Hilfinger JM; Clark N; Smith M; Robinson K; Markovitz DM
    J Virol; 1993 Jul; 67(7):4448-53. PubMed ID: 8510231
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of the human T-cell leukemia virus type I enhancer is mediated by binding sites for Elf-1 and the pets factor.
    Clark NM; Smith MJ; Hilfinger JM; Markovitz DM
    J Virol; 1993 Sep; 67(9):5522-8. PubMed ID: 8350410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The peri-kappa B site mediates human immunodeficiency virus type 2 enhancer activation in monocytes but not in T cells.
    Clark NM; Hannibal MC; Markovitz DM
    J Virol; 1995 Aug; 69(8):4854-62. PubMed ID: 7609053
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of the human immunodeficiency virus type 2 enhancer is dependent on purine box and kappa B regulatory elements.
    Markovitz DM; Smith MJ; Hilfinger J; Hannibal MC; Petryniak B; Nabel GJ
    J Virol; 1992 Sep; 66(9):5479-84. PubMed ID: 1501284
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Purification of the pets factor. A nuclear protein that binds to the inducible TG-rich element of the human immunodeficiency virus type 2 enhancer.
    Fu GK; Markovitz DM
    J Biol Chem; 1996 Aug; 271(32):19599-605. PubMed ID: 8702655
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synergistic interactions between overlapping binding sites for the serum response factor and ELK-1 proteins mediate both basal enhancement and phorbol ester responsiveness of primate cytomegalovirus major immediate-early promoters in monocyte and T-lymphocyte cell types.
    Chan YJ; Chiou CJ; Huang Q; Hayward GS
    J Virol; 1996 Dec; 70(12):8590-605. PubMed ID: 8970984
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Infection with the human immunodeficiency virus type 2.
    Markovitz DM
    Ann Intern Med; 1993 Feb; 118(3):211-8. PubMed ID: 8380244
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Establishment and characterization of a human acute monocytic leukemia cell line (THP-1).
    Tsuchiya S; Yamabe M; Yamaguchi Y; Kobayashi Y; Konno T; Tada K
    Int J Cancer; 1980 Aug; 26(2):171-6. PubMed ID: 6970727
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An undifferentiated variant derived from the human acute myelogenous leukemia cell line (KG-1).
    Koeffler HP; Billing R; Lusis AJ; Sparkes R; Golde DW
    Blood; 1980 Aug; 56(2):265-73. PubMed ID: 6967340
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.
    Gorman CM; Moffat LF; Howard BH
    Mol Cell Biol; 1982 Sep; 2(9):1044-51. PubMed ID: 6960240
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.
    Dignam JD; Lebovitz RM; Roeder RG
    Nucleic Acids Res; 1983 Mar; 11(5):1475-89. PubMed ID: 6828386
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunoglobulin gene transcription is activated by downstream sequence elements.
    Queen C; Baltimore D
    Cell; 1983 Jul; 33(3):741-8. PubMed ID: 6409419
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human leukemic models of myelomonocytic development: a review of the HL-60 and U937 cell lines.
    Harris P; Ralph P
    J Leukoc Biol; 1985 Apr; 37(4):407-22. PubMed ID: 3855947
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.